DMT

Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine)…

Dec 15, 2021

Cepharanthin To Cure COVID? PharmaDrug Perks The FDA’s Interest

Dec 14, 2021

An Inside Look at Numinus’ Progress in Psychedelic Testing

Nov 29, 2021

Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans

Nov 29, 2021

Athletes Go From Hurting To Healing With Psychedelics

Nov 26, 2021

Former UFC Champ Cain Velasquez Is The Latest Athlete To Open Up About Psychedelics

Nov 11, 2021

PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch

Nov 11, 2021

PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases

Nov 5, 2021

Algernon Pharmaceuticals’ Latest DMT Study Establishes Ideal Treatment Period

Nov 2, 2021

Small Pharma CEO On Innovative Passport Designation, Patents & More As Psychedelic Stock Surges

Nov 1, 2021